Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra

Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba
ERJ Open Research 2022 8: 00245-2022; DOI: 10.1183/23120541.00245-2022
Koji Kuronuma
1Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan
4These authors contributed equally to first authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kuronumak@sapmed.ac.jp
Natsumi Susai
2Biomarker R&D Department, Shionogi & Co., Ltd, Toyonaka, Japan
4These authors contributed equally to first authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiro Kuroita
2Biomarker R&D Department, Shionogi & Co., Ltd, Toyonaka, Japan
3Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Yamamoto
3Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Yoshioka
2Biomarker R&D Department, Shionogi & Co., Ltd, Toyonaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuji Kaneko
3Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirofumi Chiba
1Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 8 no. 4
DOI 
https://doi.org/10.1183/23120541.00245-2022

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received May 18, 2022
  • Accepted July 21, 2022
  • Published online October 24, 2022.

Article Versions

  • previous version (August 11, 2022 - 07:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Koji Kuronuma1,4⇑,
  2. Natsumi Susai2,4,
  3. Tomohiro Kuroita2,3,
  4. Hiroki Yamamoto3,
  5. Takeshi Yoshioka2,
  6. Shuji Kaneko3 and
  7. Hirofumi Chiba1
  1. 1Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan
  2. 2Biomarker R&D Department, Shionogi & Co., Ltd, Toyonaka, Japan
  3. 3Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
  4. 4These authors contributed equally to first authorship
  1. Corresponding author: Koji Kuronuma (kuronumak{at}sapmed.ac.jp)
View Full Text

Funding

  • Shionogi

Article usage

Article usage: August 2022 to December 2022

AbstractFullPdf
Aug 2022548439
Sep 2022425825
Oct 20228216134
Nov 20225228169
Dec 2022615689

Altmetrics

PreviousNext
Back to top
Vol 8 Issue 4 Table of Contents
ERJ Open Research: 8 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra
Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba
ERJ Open Research Oct 2022, 8 (4) 00245-2022; DOI: 10.1183/23120541.00245-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra
Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba
ERJ Open Research Oct 2022, 8 (4) 00245-2022; DOI: 10.1183/23120541.00245-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original research articles

  • Functional assay in CF organoids allows drug repurposing
  • Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
  • PERSPIRE: a cohort study
Show more Original research articles

Interstitial lung disease

  • Developing a self-management package for pulmonary fibrosis
  • Development and validation of an ILD exposure questionnaire
  • Effect of nintedanib on AEs of fibrosing ILDs
Show more Interstitial lung disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society